Neurogen preclinical data

NRGN (Branford, Conn.) announced animal data on NGD 95-1, an orally active small molecule for appetite suppression. Body weight differences developed between a group of healthy rats given the drug and a control group. The wieght differential continued to increase over a three-week treatment period. ...